RU98108179A - METHOD FOR TREATING INFECTIOUS MONONUCLEOSIS IN CHILDREN - Google Patents

METHOD FOR TREATING INFECTIOUS MONONUCLEOSIS IN CHILDREN

Info

Publication number
RU98108179A
RU98108179A RU98108179/14A RU98108179A RU98108179A RU 98108179 A RU98108179 A RU 98108179A RU 98108179/14 A RU98108179/14 A RU 98108179/14A RU 98108179 A RU98108179 A RU 98108179A RU 98108179 A RU98108179 A RU 98108179A
Authority
RU
Russia
Prior art keywords
children
infectious mononucleosis
treating infectious
vitamin
patient
Prior art date
Application number
RU98108179/14A
Other languages
Russian (ru)
Other versions
RU2150955C1 (en
Inventor
Л.В. Феклисова
Л.А. Галкина
М.В. Филатова
В.И. Марченко
Original Assignee
Московский областной научно-исследовательский клинический институт
Filing date
Publication date
Application filed by Московский областной научно-исследовательский клинический институт filed Critical Московский областной научно-исследовательский клинический институт
Priority to RU98108179A priority Critical patent/RU2150955C1/en
Priority claimed from RU98108179A external-priority patent/RU2150955C1/en
Publication of RU98108179A publication Critical patent/RU98108179A/en
Application granted granted Critical
Publication of RU2150955C1 publication Critical patent/RU2150955C1/en

Links

Claims (1)

Способ лечения инфекционного мононуклеоза у детей, включающий комплексную лекарственную симптоматическую и патогенетическую терапию, отличающийся тем, что дополнительно больному ректально вводят реальдирон два раза в сутки с интервалом 12 ч в течение 7 дней по 500000 ME детям от 3 до 7 лет и по 1000000 ME - старше 7 лет, с одновременным назначением альфа-токоферола (витамин E) и аскорбиновой кислоты (витамин С) в возрастных дизировках.A method of treating infectious mononucleosis in children, including complex drug symptomatic and pathogenetic therapy, characterized in that in addition to the patient, realdirone is administered rectally to the patient twice a day with an interval of 12 hours for 7 days, for 500,000 ME for children from 3 to 7 years old and for 1,000,000 ME older than 7 years, with the simultaneous administration of alpha-tocopherol (vitamin E) and ascorbic acid (vitamin C) in age-related disinfections.
RU98108179A 1998-04-29 1998-04-29 Method of treatment of children with infectious mononucleosis RU2150955C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU98108179A RU2150955C1 (en) 1998-04-29 1998-04-29 Method of treatment of children with infectious mononucleosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU98108179A RU2150955C1 (en) 1998-04-29 1998-04-29 Method of treatment of children with infectious mononucleosis

Publications (2)

Publication Number Publication Date
RU98108179A true RU98108179A (en) 2000-02-10
RU2150955C1 RU2150955C1 (en) 2000-06-20

Family

ID=20205423

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98108179A RU2150955C1 (en) 1998-04-29 1998-04-29 Method of treatment of children with infectious mononucleosis

Country Status (1)

Country Link
RU (1) RU2150955C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2555474C1 (en) * 2014-09-09 2015-07-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО РостГМУ Минздрава России) Method of treating epstein-barr viral infection in hiv-infected children

Similar Documents

Publication Publication Date Title
SE9401406L (en) Pharmaceutical products for the cure of tumor diseases as well as a method for the preparation thereof
ES2187575T3 (en) CYCLE HEXAPEPTIDES GIVEN WITH ANTIBIOTIC ACTIVITY.
DE3876877T2 (en) USE OF INDOLON DERIVATIVES FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF PARKINSONISM.
DE3879873D1 (en) PHYSIOLOGICALLY ACTIVE SUBSTANCES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE58901002D1 (en) AGENT WITH DESTROYING EFFECT ON MALIGNE TUMORS, METHOD FOR THE PRODUCTION THEREOF AND PREPARATION FOR USE IN THE THERAPY OF CANCER DISEASES.
DE68909409T2 (en) MEDICAL DOSAGE FOR ADMINISTRATION TO FISH.
FI875245A0 (en) FOERFARANDE FOER OEKANDE AV UTSOENDRINGEN AV ADENOSIN.
RU98108179A (en) METHOD FOR TREATING INFECTIOUS MONONUCLEOSIS IN CHILDREN
DE69015910T2 (en) Pharmaceutical use of fatty acids.
ATE183204T1 (en) AMINO SUGAR, GLYCOPROTEINS, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THEIR USE
KR950700737A (en) Medicine for the treatment of airways inflammation and airways hyperresponsiveness
RU93031184A (en) DRUG FOR PREVENTION AND TREATMENT OF BIRD DISEASES
PT84996A (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF BACTERIAL INFECTIONS
RU97115801A (en) METHOD FOR TREATING STENOSING LARYNGOTRACHAITIS IN CHILDREN
DE69932741D1 (en) USE OF N-GLYCOL NEURAMIC ACID AND THEIR DERIVATIVES FOR THE PRODUCTION OF A MEDICAMENT FOR THE TREATMENT OF HIV INFECTIONS
SU1703118A1 (en) Method for treating the cases of herpetic stomatitis in children
PT85076A (en) Method for the treatment of infections disease by administration of tumor necrosis factor-alpha
ATE12649T1 (en) OPTICALLY ACTIVE DIPEPTIDE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
RU2026066C1 (en) Method for removing plutonium-239 ingressed via lungs
RU97115829A (en) METHOD FOR TREATING PERFORMANCE OF COLLUS IN CHILDREN
RU94036169A (en) Method for treating hepatitis
RU93003456A (en) PREPARATION
RU96120000A (en) METHOD FOR TREATING INFECTIO-ALLERGIC RHINOSYNOSOPATHY
DK601788D0 (en) APPLICATION OF ANTIBIOTICS LL-E19020ALFA AND LL-E19020BETA TO TREAT CERTAIN PERSONAL DISEASES
RU99108209A (en) METHOD FOR TREATMENT OF THE CIRCULAR RETINOPATHY PHASE OF UNMOUNTED CHILDREN